Potent nasal vaccine protects non-human primates from SARS-CoV-2

By | July 21, 2021
A team of US-based scientists has recently demonstrated the efficacy of a live attenuated, recombinant coronavirus disease 2019 (COVID-19) vaccine candidate currently under phase I clinical trial as a single-dose intranasal vaccine.